Pesquisas alternativas:
disease level » disease levels (Expandir a Pesquisa), disease liver (Expandir a Pesquisa), disease like (Expandir a Pesquisa)
drug disease » lung disease (Expandir a Pesquisa), drug release (Expandir a Pesquisa)
dose levels » noise levels (Expandir a Pesquisa)
levels ther » levels other (Expandir a Pesquisa), levels rather (Expandir a Pesquisa), levels three (Expandir a Pesquisa)
devel ther » novel ther (Expandir a Pesquisa), level theory (Expandir a Pesquisa), develop them (Expandir a Pesquisa)
level ther » level theory (Expandir a Pesquisa), level rather (Expandir a Pesquisa), levels other (Expandir a Pesquisa)
drug dose » drug dosage (Expandir a Pesquisa)
de devel » de deve (Expandir a Pesquisa), de dever (Expandir a Pesquisa), de deber (Expandir a Pesquisa)
drug de » drug dna (Expandir a Pesquisa)
disease level » disease levels (Expandir a Pesquisa), disease liver (Expandir a Pesquisa), disease like (Expandir a Pesquisa)
drug disease » lung disease (Expandir a Pesquisa), drug release (Expandir a Pesquisa)
dose levels » noise levels (Expandir a Pesquisa)
levels ther » levels other (Expandir a Pesquisa), levels rather (Expandir a Pesquisa), levels three (Expandir a Pesquisa)
devel ther » novel ther (Expandir a Pesquisa), level theory (Expandir a Pesquisa), develop them (Expandir a Pesquisa)
level ther » level theory (Expandir a Pesquisa), level rather (Expandir a Pesquisa), levels other (Expandir a Pesquisa)
drug dose » drug dosage (Expandir a Pesquisa)
de devel » de deve (Expandir a Pesquisa), de dever (Expandir a Pesquisa), de deber (Expandir a Pesquisa)
drug de » drug dna (Expandir a Pesquisa)
1
“... it might be a neuroprotective and disease-modifying drug. Data from ongoing clinical trials of pridopidine...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2
Por de Leeuw, Erik PH
Publicado em 2014
“... compound that targets Lipid II is described that acts against multi-drug resistant isolates of A. baumannii...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
3
Por Okparavero, Aghogho A, Tighiouart, Hocine, Krishnasami, Zipporah, Wyatt, Christina M, Graham, Hiba, Hellinger, James, Inker, Lesley A
Publicado em 2013
“... antiretroviral drug dosing for level of kidney function in 200 HIV-positive patients on stable antiretroviral...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
5
Por Takeuchi, Tsutomu, Miyasaka, Nobuyuki, Inui, Takashi, Yano, Toshiro, Yoshinari, Toru, Abe, Tohru, Koike, Takao
Publicado no Arthritis Res Ther (2017)
“... TNF level, serum infliximab level, and disease activity were compared between the three classes...”Publicado no Arthritis Res Ther (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
“... and was related to serum and cerebrospinal fluid drug levels. Repeated 2-week treatment with risperidone...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
7
Por de Oliveira Magalhães, Uiaran, de Souza, Alessandra Mendonça Teles, Albuquerque, Magaly Girão, de Brito, Monique Araújo, Bello, Murilo Lamim, Cabral, Lucio Mendes, Rodrigues, Carlos Rangel
Publicado em 2013
“... immunodeficiency virus (HIV). Treatment with antiretroviral drugs is the best option for viral suppression...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
8
Por de Farias, Pablo Antonio Maia, Figueredo, Fernando Gomes, Lucas, Aline Maria Brito, de Moura, Rafael Barbosa, Coutinho, Henrique Douglas Melo, da Silva, Tania Maria Sarmento, Martin, Ana Luiza de Aguiar Rocha, Fonteles, Marta Maria de França
Publicado no Drug Des Devel Ther (2015)
“... in the drug dose required and possibly in consequent adverse events for patients....”Publicado no Drug Des Devel Ther (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
Por Rezende, Vinicius Marcondes, Rivellis, Ariane, Novaes, Mafalda Megumi Yoshinaga, de Alencar Fisher Chamone, Dalton, Bendit, Israel
Publicado em 2013
“... standard for monitoring patients, and imatinib blood levels have also become an important tool...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
Por Ruiz de Garibay, Aritz Pérez, Delgado, Diego, del Pozo-Rodríguez, Ana, Solinís, María Ángeles, Gascón, Alicia Rodríguez
Publicado em 2012
“... for the treatment of Fabry disease (FD). The objective of the present study was to demonstrate the potential...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
“...For almost three decades ambroxol has been used in the therapy of airway diseases. In 2002...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
Por Scheinberg, Morton, Pott Júnior, Henrique, Macêdo, Eduardo de Almeida, Bocchi de Oliveira, Monalisa Fernanda, Ecclissato, Christina, Amazonas, Roberto Bleuel
Publicado no Drug Des Devel Ther (2018)
“...PURPOSE: This study investigated the safety and efficacy of fixed-dose combination tablets...”Publicado no Drug Des Devel Ther (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
13
Por van Vollenhoven, Ronald, Helt, Cameron, Arora, Vipin, Zhong, Jinglin, Correia, Ana Pinto, de la Torre, Inma, Muram, David
Publicado no Rheumatol Ther (2018)
“... response at the 20% improvement level (ACR20) and Clinical Disease Activity Index (CDAI) ≤ 10 at week 12...”Publicado no Rheumatol Ther (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
14
Por Schub, David, Assmann, Gunter, Sester, Urban, Sester, Martina, Schmidt, Tina
Publicado no Arthritis Res Ther (2018)
“... their levels and functionality were impacted by disease-modifying antirheumatic drugs (DMARDs). A polyclonal...”Publicado no Arthritis Res Ther (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
Por Mazo, Daniel FC, de Oliveira, Marcelo G, Pereira, Isabel VA, Cogliati, Bruno, Stefano, José T, de Souza, Gabriela FP, Rabelo, Fabíola, Lima, Fabiana R, Alves, Venâncio A Ferreira, Carrilho, Flair J, de Oliveira, Claudia PMS
Publicado em 2013
Obter o texto integralPublicado em 2013
Obter o texto integral
Obter o texto integral
Artigo
17
Por Papangkorn, Kongnara, Higuchi, John W., Brar, Balbir, Higuchi, William I.
Publicado no J Ocul Pharmacol Ther (2018)
“... and in plasma after single administrations of DSP-Visulex. The drug in eye tissues and plasma was analyzed...”Publicado no J Ocul Pharmacol Ther (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18
19
“... disease or on dialysis must await dosing recommendations. Sofosbuvir-based regimens appear to be well...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
20
Por Bacci, Marcelo Rodrigues, Cavallari, Marina Romera, de Rozier-Alves, Ross Martin, Alves, Beatriz da Costa Aguiar, Fonseca, Fernando Luiz Affonso
Publicado no Drug Des Devel Ther (2015)
“.... It is expected that the levels of BTP in patients with cardiovascular disease are elevated, as is the case...”Publicado no Drug Des Devel Ther (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo